ALX Oncology Exchanges 13.35 Million Shares for Pre-Funded Warrants
ALX Oncology entered separate privately negotiated agreements with key shareholders to exchange 13,353,384 common shares for pre-funded warrants exercisable at $0.001 per share.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
ALX Oncology Exchanges 13,353,384 Common Shares for Pre — Funded Warrants
ALX Oncology agreed October 14, 2026, to exchange 13,353,384 common shares for pre-funded warrants covering the same number of shares. Blackstone-affiliated funds account for 12,885,891 shares; RA Capital Healthcare Fund, 213,667; venBio Global Strategic Fund, 253,826. The unregistered issuance relies on a Section 3(a)